Lantheus Holdings (LNTH) Non Operating Investment Income (2024 - 2026)

Lantheus Holdings' (LNTH) quarterly Non Operating Investment Income came in at $14.9 million in Q1 2026, up 200.29% year-on-year from $5.0 million in Q1 2025, and up 257.09% on a QoQ basis from -$9.5 million in Q4 2025.

Lantheus Holdings (LNTH) Non Operating Investment Income (2024 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 3 years of Non Operating Investment Income data on file, last reported at $14.9 million in Q1 2026.

  • On a quarterly basis, Non Operating Investment Income rose 200.29% year-over-year to $14.9 million in Q1 2026; TTM through Mar 2026 was $21.2 million, a 117.75% increase from a year earlier, with the FY2025 full-year figure at -$8.6 million, up 80.22% from the prior year.
  • Non Operating Investment Income for Q1 2026 stood at $14.9 million, up from -$9.5 million in the prior quarter.
  • Over the last five years, Non Operating Investment Income for LNTH reached as high as $60.7 million in Q1 2024 and fell as low as -$119.1 million in Q4 2024.
  • Historically, Non Operating Investment Income has averaged -$4.1 million across 3 years, with a median of $1.2 million in 2025.
  • Across the five-year window, Non Operating Investment Income sank 124.48% in 2025 and soared 200.29% in 2026, its largest moves.
  • Year by year, Non Operating Investment Income stood at -$119.1 million in 2024, then surged by 92.03% to -$9.5 million in 2025, then soared by 257.09% to $14.9 million in 2026.
  • Per Business Quant data, the three most recent Non Operating Investment Income figures were $14.9 million in Q1 2026, -$9.5 million in Q4 2025, and $1.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Lantheus Holdings 7.04 Bn 6.54 Bn 230.92 Mn 14.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 14.91 Mn
Mar 31, 2026 14.91 Mn
Dec 31, 2025 -9.49 Mn
Dec 31, 2025 -9.49 Mn
Sep 30, 2025 1.16 Mn
Sep 30, 2025 1.16 Mn
Jun 30, 2025 14.57 Mn
Jun 30, 2025 14.57 Mn
Mar 31, 2025 -14.86 Mn
Mar 31, 2025 -14.86 Mn
Dec 31, 2024 -119.06 Mn
Dec 31, 2024 -119.06 Mn
Sep 30, 2024 37.33 Mn
Sep 30, 2024 37.33 Mn
Jun 30, 2024 -22.54 Mn
Jun 30, 2024 -22.54 Mn
Mar 31, 2024 60.70 Mn
Mar 31, 2024 60.70 Mn